Alerts will be sent to your verified email
Verify EmailEIKO
Eiko Lifesciences
|
Malpani Pipes&Fittin
|
Daikaffil Chemicals
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-16.62 % | 36.38 % | 6.38 % |
5yr average Equity Multiplier
|
2.12 | 5.49 | 1.45 |
5yr Average Asset Turnover Ratio
|
0.56 | 2.02 | 0.9 |
5yr Avg Net Profit Margin
|
-3.7 % | 3.44 % | 6.38 % |
Price to Book
|
1.29 | 0.0 | 8.92 |
P/E
|
27.43 | 9.8 | 0.0 |
5yr Avg Cash Conversion Cycle
|
61.48 Days | 54.52 Days | 0.0 |
Inventory Days
|
214.38 Days | 53.51 Days | 38.98 Days |
Days Receivable
|
57.98 Days | 22.71 Days | 0.0 |
Days Payable
|
248.22 Days | 43.7 Days | 42.46 Days |
5yr Average Interest Coverage Ratio
|
-0.09 | 3.68 | -50.82 |
5yr Avg ROCE
|
-109.51 % | 30.42 % | 10.77 % |
5yr Avg Operating Profit Margin
|
-9.68 % | 6.76 % | 10.31 % |
5 yr average Debt to Equity
|
0.3 | 2.6 | 0.05 |
5yr CAGR Net Profit
|
60.2 % | 52.75 % | n/a |
5yr Average Return on Assets
|
-4.56 % | 7.19 % | 3.22 % |
Shareholdings
|
|||
Promoter Holding
|
37.11 % | 73.28 % | 52.65 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
23.63 % | 0.0 | 21.46 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Eiko Lifesciences
|
Malpani Pipes&Fittin
|
Daikaffil Chemicals
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|